A citation-based method for searching scientific literature

Roger S McIntyre, Mehala Subramaniapillai, Yena Lee, Zihang Pan, Nicole E Carmona, Margarita Shekotikhina, Joshua D Rosenblat, Elisa Brietzke, Joanna K Soczynska, Victoria E Cosgrove, Shefali Miller, Eileen Grace Fischer, Nicole E Kramer, Kiley Dunlap, Trisha Suppes, Rodrigo B Mansur. JAMA Psychiatry 2019
Times Cited: 58







List of co-cited articles
540 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
833
56



Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies.
Amirhossein Modabbernia, Shervin Taslimi, Elisa Brietzke, Mandana Ashrafi. Biol Psychiatry 2013
327
18


From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
15

Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials.
O Köhler-Forsberg, C N Lydholm, C Hjorthøj, M Nordentoft, O Mors, M E Benros. Acta Psychiatr Scand 2019
82
15

A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
13

Inflammation and clinical response to treatment in depression: A meta-analysis.
R Strawbridge, D Arnone, A Danese, A Papadopoulos, A Herane Vives, A J Cleare. Eur Neuropsychopharmacol 2015
270
13


Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial.
Muhammad I Husain, Imran B Chaudhry, Nusrat Husain, Ameer B Khoso, Raza R Rahman, Munir M Hamirani, John Hodsoll, Inti Qurashi, John Fw Deakin, Allan H Young. J Psychopharmacol 2017
60
13

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Andrea Cipriani, Toshi A Furukawa, Georgia Salanti, Anna Chaimani, Lauren Z Atkinson, Yusuke Ogawa, Stefan Leucht, Henricus G Ruhe, Erick H Turner, Julian P T Higgins,[...]. Lancet 2018
784
13

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
Ole Köhler, Michael E Benros, Merete Nordentoft, Michael E Farkouh, Rupa L Iyengar, Ole Mors, Jesper Krogh. JAMA Psychiatry 2014
426
13

Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis.
Joshua D Rosenblat, Ron Kakar, Michael Berk, Lars V Kessing, Maj Vinberg, Bernhard T Baune, Rodrigo B Mansur, Elisa Brietzke, Benjamin I Goldstein, Roger S McIntyre. Bipolar Disord 2016
98
13

Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial.
Jonathan B Savitz, T Kent Teague, Masaya Misaki, Matt Macaluso, Brent E Wurfel, Matt Meyer, Douglas Drevets, William Yates, Ondria Gleason, Wayne C Drevets,[...]. Transl Psychiatry 2018
57
14

Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial.
Muhammad Ishrat Husain, Imran B Chaudhry, Ameer B Khoso, Muhammad Omair Husain, John Hodsoll, Moin A Ansari, Haider A Naqvi, Fareed A Minhas, Andre F Carvalho, Jeffrey H Meyer,[...]. Lancet Psychiatry 2020
23
34

Biomarker-Guided Anti-inflammatory Therapies: From Promise to Reality Check.
Michael Berk, Adam J Walker, Andrew A Nierenberg. JAMA Psychiatry 2019
9
77

Treatment-resistant depression and peripheral C-reactive protein.
Samuel R Chamberlain, Jonathan Cavanagh, Peter de Boer, Valeria Mondelli, Declan N C Jones, Wayne C Drevets, Philip J Cowen, Neil A Harrison, Linda Pointon, Carmine M Pariante,[...]. Br J Psychiatry 2019
88
12

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.
Jonas Hannestad, Nicole DellaGioia, Michael Bloch. Neuropsychopharmacology 2011
528
12

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
12

Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study.
M H Rapaport, A A Nierenberg, P J Schettler, B Kinkead, A Cardoos, R Walker, D Mischoulon. Mol Psychiatry 2016
140
12

Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis.
Klaus Munkholm, Julie Vestergaard Braüner, Lars Vedel Kessing, Maj Vinberg. J Psychiatr Res 2013
233
12


Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.
M Berk, F Kapczinski, A C Andreazza, O M Dean, F Giorlando, M Maes, M Yücel, C S Gama, S Dodd, B Dean,[...]. Neurosci Biobehav Rev 2011
734
12

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, Ayal Schaffer, David J Bond, Benicio N Frey, Verinder Sharma, Benjamin I Goldstein, Soham Rej, Serge Beaulieu,[...]. Bipolar Disord 2018
402
12

The new field of 'precision psychiatry'.
Brisa S Fernandes, Leanne M Williams, Johann Steiner, Marion Leboyer, André F Carvalho, Michael Berk. BMC Med 2017
149
10

Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression.
E Haroon, C C Fleischer, J C Felger, X Chen, B J Woolwine, T Patel, X P Hu, A H Miller. Mol Psychiatry 2016
108
10

Novel therapeutic targets in depression: minocycline as a candidate treatment.
Joanna K Soczynska, Rodrigo B Mansur, Elisa Brietzke, Walter Swardfager, Sidney H Kennedy, Hanna O Woldeyohannes, Alissa M Powell, Marena S Manierka, Roger S McIntyre. Behav Brain Res 2012
108
10

Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression.
Yena Lee, Mehala Subramaniapillai, Elisa Brietzke, Rodrigo B Mansur, Roger C Ho, Samantha J Yim, Roger S McIntyre. Ther Adv Psychopharmacol 2018
25
24

Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression.
J C Felger, Z Li, E Haroon, B J Woolwine, M Y Jung, X Hu, A H Miller. Mol Psychiatry 2016
229
10

Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.
C A Köhler, T H Freitas, M Maes, N Q de Andrade, C S Liu, B S Fernandes, B Stubbs, M Solmi, N Veronese, N Herrmann,[...]. Acta Psychiatr Scand 2017
406
10

Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels.
Emanuele Felice Osimo, Luke James Baxter, Glyn Lewis, Peter B Jones, Golam M Khandaker. Psychol Med 2019
84
10

A new depression scale designed to be sensitive to change.
S A Montgomery, M Asberg. Br J Psychiatry 1979
10

So depression is an inflammatory disease, but where does the inflammation come from?
Michael Berk, Lana J Williams, Felice N Jacka, Adrienne O'Neil, Julie A Pasco, Steven Moylan, Nicholas B Allen, Amanda L Stuart, Amie C Hayley, Michelle L Byrne,[...]. BMC Med 2013
565
8

An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
Rudolf Uher, Katherine E Tansey, Tracy Dew, Wolfgang Maier, Ole Mors, Joanna Hauser, Mojca Zvezdana Dernovsek, Neven Henigsberg, Daniel Souery, Anne Farmer,[...]. Am J Psychiatry 2014
196
8

Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration.
Lucile Capuron, Giuseppe Pagnoni, Daniel F Drake, Bobbi J Woolwine, James R Spivey, Ronald J Crowe, John R Votaw, Mark M Goodman, Andrew H Miller. Arch Gen Psychiatry 2012
209
8

Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial.
Olivia M Dean, Buranee Kanchanatawan, Melanie Ashton, Mohammadreza Mohebbi, Chee Hong Ng, Michael Maes, Lesley Berk, Atapol Sughondhabirom, Sookjaroen Tangwongchai, Ajeet B Singh,[...]. Aust N Z J Psychiatry 2017
47
10

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
8

Cytokines sing the blues: inflammation and the pathogenesis of depression.
Charles L Raison, Lucile Capuron, Andrew H Miller. Trends Immunol 2006
8

Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.
Divya Mehta, Charles L Raison, Bobbi J Woolwine, Ebrahim Haroon, Elisabeth B Binder, Andrew H Miller, Jennifer C Felger. Brain Behav Immun 2013
43
11

Social stress induces neurovascular pathology promoting depression.
Caroline Menard, Madeline L Pfau, Georgia E Hodes, Veronika Kana, Victoria X Wang, Sylvain Bouchard, Aki Takahashi, Meghan E Flanigan, Hossein Aleyasin, Katherine B LeClair,[...]. Nat Neurosci 2017
249
8

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
8

CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
C L Raison, R Dantzer, K W Kelley, M A Lawson, B J Woolwine, G Vogt, J R Spivey, K Saito, A H Miller. Mol Psychiatry 2010
401
8

Can't or Won't? Immunometabolic Constraints on Dopaminergic Drive.
Michael T Treadway, Jessica A Cooper, Andrew H Miller. Trends Cogn Sci 2019
28
17

Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation.
Andrew H Miller, Ebrahim Haroon, Jennifer C Felger. Neuropsychopharmacology 2017
63
8

C-reactive protein alterations in bipolar disorder: a meta-analysis.
Aroldo A Dargél, Ophelia Godin, Flávio Kapczinski, David J Kupfer, Marion Leboyer. J Clin Psychiatry 2015
85
8

A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
8

A clinical model for identifying an inflammatory phenotype in mood disorders.
Nicole E Kramer, Victoria E Cosgrove, Kiley Dunlap, Mehala Subramaniapillai, Roger S McIntyre, Trisha Suppes. J Psychiatr Res 2019
6
83

The macrophage theory of depression.
R S Smith. Med Hypotheses 1991
598
8

Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I/II depression.
Yena Lee, Rodrigo B Mansur, Elisa Brietzke, Nicole E Carmona, Mehala Subramaniapillai, Zihang Pan, Margarita Shekotikhina, Joshua D Rosenblat, Trisha Suppes, Victoria E Cosgrove,[...]. Brain Behav Immun 2020
12
41


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.